A Systematic Immune and Prognostic Analysis of CD48 Interaction with Tumor Microenvironment in Pan-Cancer.
Mingdong HeJun YuShaohua ChenHua MiPublished in: International journal of general medicine (2023)
Concludingly, patients with pan-cancer may benefit from evaluating CD48 as a prognostic and immunotherapy response biomarker.